A detailed history of Thoroughbred Financial Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 21,522 shares of NVO stock, worth $2.83 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
21,522
Previous 34,704 37.98%
Holding current value
$2.83 Million
Previous $3.59 Million 23.04%
% of portfolio
0.27%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $1.35 Million - $1.79 Million
-13,182 Reduced 37.98%
21,522 $2.76 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $1.33 Million - $1.6 Million
15,167 Added 77.63%
34,704 $3.59 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $1.66 Million - $3.64 Million
18,253 Added 1421.57%
19,537 $1.78 Million
Q2 2023

Aug 03, 2023

BUY
$155.98 - $172.65 $200,278 - $221,682
1,284 New
1,284 $207,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $297B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.